XML 44 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK COMPENSATION PLANS (Details) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
May 25, 2005
Non-vested shares of Class A Stock under option [Abstract]          
Vesting period for granted option (in years)     1 year    
Options granted term (in years)     10 years    
Weighted-average assumptions used for grants issued [Abstract]          
Expected Dividend Yield (in hundredths)     3.63% 4.18%  
Expected Stock Price Volatility (in hundredths)     26.16% 25.13%  
Weighted Average Risk-Free Interest Rate (in hundredths)     1.68% 1.87%  
Weighted Average Expected Life of Options (in years)     9 years 4 months 28 days 9 years 5 months 19 days  
Base period for calculation of expected dividend yield (in months)     12 months    
Unrecognized expense related to non-vested option shares $ 82,000   $ 82,000    
Period over which unvested options cost will recognized (in years)     7 months 6 days    
Class A Stock [Member] | 2005 Equity Compensation Plan [Member]
          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorizes for new issues         500,000
Compensation expense 34,000 25,000 89,000 83,000  
Class A Stock [Member] | Stock Options [Member]
          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Outstanding at beginning of period, option shares (in shares)     421,500    
Granted, option shares (in shares)     33,750    
Exercised, option shares (in shares)     (43,500)    
Expired, option shares (in shares)     0    
Outstanding at end of period, option shares (in shares) 411,750   411,750    
Options exercisable at end of period, option share (in shares) 378,000   378,000    
Shares of Class A Non-Voting Common Stock under option [Abstract]          
Outstanding at beginning of period, weighted average exercise price (in dollars per shares)     $ 18.30    
Outstanding at beginning of period, weighted average remaining life (in years)     4 years 6 months 14 days    
Granted, weighted average exercise price (in dollars per shares)     $ 22.66    
Exercised, weighted average exercise price (in dollars per shares)     $ 16.08    
Outstanding at end of period, weighted average exercise price (in dollars per shares) $ 18.89   $ 18.89    
Options exercisable at end of period, weighted average exercise price (in dollars per shares) $ 18.56   $ 18.56    
Outstanding at end of period, weighted average remaining life (in years)     4 years 6 months 14 days    
Options exercisable at end of period, weighted average remaining life (in years)     4 years 1 month 2 days    
Options exercisable at beginning of period, aggregate intrinsic value     1,741,000    
Exercised, aggregate intrinsic value     254,000    
Outstanding at end of period, aggregate intrinsic value 1,397,000   1,397,000    
Options exercisable at end of period, aggregate intrinsic value $ 1,397,000   $ 1,397,000    
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding [Roll Forward]          
Granted, option shares (in shares)     33,750    
Class A Stock [Member] | Non-Vested Stock Option [Member]
          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Granted, option shares (in shares)     33,750    
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding [Roll Forward]          
Outstanding at beginning of period, Non-vested option shares (in shares)     33,750    
Granted, option shares (in shares)     33,750    
Vested, option shares (in shares)     (33,750)    
Canceled, option shares (in shares)     0    
Outstanding at end of period, Non-vested option shares (in shares) 33,750   33,750    
Non-vested shares of Class A Stock under option [Abstract]          
Outstanding at beginning of period, weighted average grant - date fair value per option (in dollars per shares)     $ 2.92    
Granted, weighted average grant - date fair value per option (in dollars per shares)     $ 4.04    
Vested, weighted average grant - date fair value per option (in dollars per shares)     $ 2.92    
Canceled, weighted average grant - date fair value per option (in dollars per shares)     $ 0    
Outstanding at end of period, weighted average grant - date fair value per option (in dollars per shares) $ 4.04   $ 4.04